Ticker
TARSCompany Name
TARSUS PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Inventory | Inventory to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 494.99M | $ 6.41M | 1.29% |
3/31/2025 | $ 500.75M | $ 5.24M | 1.05% |
12/31/2024 | $ 376.99M | $ 5.15M | 1.37% |
9/30/2024 | $ 376.3M | $ 5.38M | 1.43% |
6/30/2024 | $ 376.84M | $ 4.73M | 1.25% |
3/31/2024 | $ 349.28M | $ 4.04M | 1.16% |
12/31/2023 | $ 265.49M | $ 3.11M | 1.17% |
9/30/2023 | $ 268.33M | $ 15K | 0.01% |
6/30/2023 | $ 188.93M | $ 0 | 0% |
3/31/2023 | $ 211.21M | $ 0 | 0% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Inventory / Assets
(=) Inv. to Assets
Inv. to Assets for TARSUS PHARMACEUTICALS INC is calculated as follows: Inventory [ $ 0 ] / Assets [ $ 92.19M ]
(=) Inv. to Assets [ 0% ]
Minimum
Sep 30, 2020
Maximum
Sep 30, 2024
Average
Median
filtered constituents | 4.46K |
---|---|
min | 0% |
max | 98.39% |
average | 6.09% |
median | 0% |
std | 11.11% |